Gene Logic Drug Repositioning Program Discovery Results in Filing of New Therapeutic Use Patent by Pfizer
GAITHERSBURG, Md.--Gene Logic Inc. (NASDAQ: GLGC) announced today recognition of a collaboration milestone, triggered by the filing of a patent application for a new use of an existing Pfizer drug candidate to treat solid tumors. The new use for the …